Related content

Alemtuzumab in chronic lymphocytic leukemia

By James Danelle F   Kipps Thomas J  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 29-42

Future Medicine

Access to resources Recommend Favorite

Antikörpertherapie in klinischer und präklinischer Anwendung bei gastrointestinalen Karzinomen

By Thalheimer A.   Braendlein S.   Vollmers P.   Thiede A.   Meyer D.   Illert B.  

Der Onkologe, Vol. 13, Iss. 3, 2007-03 ,pp. : 236-249

Springer Publishing Company

Access to resources Recommend Favorite

Alemtuzumab in CLL and Other Lymphoid Neoplasms

By Ravandi Farhad   O'Brien Susan  

Cancer Investigation, Vol. 24, Iss. 7, 2006-09 ,pp. : 718-725

Informa Healthcare

Access to resources Recommend Favorite

Die Hepatische Bilirubinaufnahme und Bilirubinelimination bei Unbestrahlten Kaninchen und Nach Bestrahlung Mit Cs-Gammastrahlen

By Schmidt M.   Souchon F.   Kriegel H.   Stich W.  

International Journal of Radiation Biology, Vol. 18, Iss. 6, 1970-12 ,pp. : 595-598

Informa Healthcare

Access to resources Recommend Favorite

Successful treatment of cancer-associated retinopathy with alemtuzumab

By Espandar Ladan   O’Brien Susan   Thirkill Charles   Lubecki Linda   Esmaeli Bita  

Journal of Neuro-Oncology, Vol. 83, Iss. 3, 2007-07 ,pp. : 295-302

Springer Publishing Company

Access to resources Recommend Favorite